Your browser doesn't support javascript.
loading
Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience.
Testi, Anna Maria; Mohamed, Sara; Diverio, Daniela; Piciocchi, Alfonso; Menna, Giuseppe; Rizzari, Carmelo; Timeus, Fabio; Micalizzi, Concetta; Lo Nigro, Luca; Santoro, Nicola; Masetti, Riccardo; Micheletti, Maria Vittoria; Ziino, Ottavio; Onofrillo, Daniela; Ladogana, Saverio; Putti, Caterina; Pierani, Paolo; Arena, Valentina; Zecca, Marco; Foà, Robin; Locatelli, Franco.
Afiliação
  • Testi AM; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Mohamed S; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Diverio D; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Piciocchi A; GIMEMA Foundation, Rome, Italy.
  • Menna G; Department of Pediatric Hemato-Oncology, A.O.R.N, Santobono-Pausilipon, Naples, Italy.
  • Rizzari C; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Monza, Italy.
  • Timeus F; Department of Pediatrics, Pediatric Onco-Hematology, Regina Margherita Children's Hospital, Chivasso Hospital, Turin, Italy.
  • Micalizzi C; Hematology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Lo Nigro L; Center of Pediatric Hematology Oncology, Azienda Policlinico-OVE, Catania, Italy.
  • Santoro N; Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Bari, Italy.
  • Masetti R; Department of Pediatrics, "Lalla Seràgnoli", Hematology-Oncology Unit, University of Bologna, Bologna, Italy.
  • Micheletti MV; Pediatric Hematology, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Ziino O; Department of Pediatric Haemato-Oncology, ARNAS Civico e Di Cristina, Palermo, Italy.
  • Onofrillo D; Paediatric Haemato-Oncology Unit, Hematology Department, Hospital of Pescara, Pescara, Italy.
  • Ladogana S; Department of Pediatrics, Hemato-Oncology Unit, 'Casa Sollievo della Sofferenza' Hospital, San Giovanni Rotondo, Italy.
  • Putti C; Department of Woman and Child Health, Clinic of Pediatric Haematology-Oncology, University of Padova, Padova, Italy.
  • Pierani P; Division of Pediatric Hematology and Oncology, Ospedale G. Salesi, Ancona, Italy.
  • Arena V; GIMEMA Foundation, Rome, Italy.
  • Zecca M; Department of Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Foà R; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Locatelli F; Department of Pediatric Hematology-Oncology and Cell and Gene Therapy, IRCCS "Bambino Gesù" Children's Hospital, Rome, Italy.
Br J Haematol ; 195(2): 278-283, 2021 10.
Article em En | MEDLINE | ID: mdl-34145572

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Trióxido de Arsênio / Gemtuzumab / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Trióxido de Arsênio / Gemtuzumab / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália